ask="0.54"
ask_size="2000"
average_daily_volume="605689"
bid="0.50"
bid_size="700"
book_value="0.81"
change="+0.01"
change_from_200_day_moving_average="-0.11"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-0.91"
change_From_52_week_low="0.18"
change_in_percent="+2.02%"
close="0.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-17.93M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.57"
ex_dividend_date="N/A"
float_shares="29657000"
high="0.54"
high_52_weeks="1.42"
last_trade_date="1/3/2017"
last_trade_price="0.51"
last_trade_size="300"
last_trade_time="4:00pm"
low="0.51"
low_52_weeks="0.33"
market_capitalization="15.31M"
moving_average_200_day="0.62"
moving_average_50_day="0.49"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.90"
open="0.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.08%"
percent_change_from_50_day_moving_average="+4.99%"
percent_change_from_52_week_high="-64.08%"
percent_change_from_52_week_low="+54.08%"
previous_close="0.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.61"
price_per_sales="1.35"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.22"
stock_exchange="NCM"
symbol="OGXI"
volume="117568"
weeks_range_52="0.33 - 1.42"
